Postpartum depression: oxytocin alters recognition of infant sadness, with no demonstrated clinical benefit

A trial comparing oxytocin with a placebo

Participants had an infant aged 3 to 9 months and clinically relevant scores on the Edinburgh Postnatal Depression Scale. Of these, 35 met the criteria for a major depressive episode, assessed through a structured clinical interview.

The study was randomized, double-blind, and crossover: each mother received oxytocin during one session and a placebo during another, in a randomized, counterbalanced order. A period without administration separated the sessions. This design allows researchers to compare the same participant’s responses under both conditions.

The researchers used an infant facial expression recognition task and recordings of infant laughter. They collected physiological measurements and self-reported responses. The abstract consulted specifies neither the dose nor the time between sessions.

An effect specific to certain emotional responses

With oxytocin, participants recognized sad infant faces more accurately. Their tendency to attribute an emotion also shifted from fear toward sadness. This result therefore does not represent a general improvement in recognizing positive emotions.

The authors suggest that this shift reflects attention directed more toward infant cues of need than toward cues of threat. This is an interpretation of the mechanism, not proof that mothers subsequently respond more appropriately to their child.

Oxytocin also increased heart rate in response to infant laughter. However, self-reported emotions and caregiving intentions did not change. A stronger physiological reaction is therefore not enough to establish an emotional or parenting benefit.

The therapeutic implications remain to be determined

Greater sensitivity to sadness could help mothers identify a baby’s needs. But the authors also note that an excessive focus on distress could intensify negative emotions in some vulnerable mothers. Neither consequence is established by the reported results.

The next question concerns caregiving behavior in real-life settings and differences between participants, particularly according to depression severity or trauma history. This trial does not support presenting oxytocin as a proven treatment for postpartum depression.

What we can take away

Oxytocin appears to selectively alter the perception of certain infant cues. The study demonstrates neither an improvement in depression nor a benefit for infant care.